Stifel Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $28
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $32
Buy Rating for DENTSPLY SIRONA on Next-Gen Dental Innovations and Strategic Growth Potential
Baird Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $31
Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Announces Target Price $34
Piper Sandler Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $32
Evercore Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Raises Target Price to $29
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and Travere Therapeutics (TVTX)
Piper Sandler Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)
Is DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Trading At A 20% Discount?
DENTSPLY SIRONA (XRAY) Is Transforming In-House Denture Production
Dentsply Sirona To Go Ex-Dividend On September 27th, 2024 With 0.16 USD Dividend Per Share
Dentsply Sirona Analyst Ratings
Barrington Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $36
DENTSPLY SIRONA: Poised for Growth With Strategic Initiatives and Strong FY/26 Targets—A Buy Recommendation
Even After Rising 3.6% This Past Week, DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Are Still Down 54% Over the Past Three Years
Germany Dental Light Cure Equipment Market Outlook to 2033 Featuring 3M, Dentsply Sirona, Henkel, Ivoclar Vivadent, Kerr, Ultradent Products
Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Buy Rating
DENTSPLY SIRONA (XRAY) Receives a Buy From Leerink Partners